To avoid overlaps, the industry is calling for aligning MDR/IVDR with the EU's digital frameworks, pharmaceutical regulations, and clinical trial regulations.

However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...

The Minister of the Federal Capital Territory, Nyesom Wike, has offered to offset the medical bills of victims of an accident ...

The warning comes amid reports that unregulated therapies are being offered directly to patients, potentially illegally. View ...

HTA as described by the HTA Regulation is the multidisciplinary scientific evidence-based process that allows to determine the relative effectiveness of new or existing health technologies. HTA is a ...

The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...